These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6428361)

  • 1. [Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].
    Denis B; Dimitriou R; Machecourt J; Wolf JE; Page E; Reboud JP
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():35-40. PubMed ID: 6428361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
    Denis B; Machecourt J; Denis MC; Morena H; Pellet J; Rossignol B; Martin-Noël P
    Arch Mal Coeur Vaiss; 1979 Sep; 72(9):1014-22. PubMed ID: 116612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M; Cuppone R; Ricci GL
    Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC; Bräuninger HJ
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of verapamil in the prevention of ventricular fibrillation in the acute phase of myocardial infarction].
    Rolli A; Favaro L; Finardi A; Aurier E; Bonatti V; Botti G
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):907-11. PubMed ID: 2461179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
    Waldorff S; Buch J
    Eur J Cardiol; 1979 Aug; 10(2):143-9. PubMed ID: 477703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F; Remonda G; Morachioli N; Pugnani M
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M; Vizzini GB
    Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Tartagni F; Ambrosioni E
    Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
    [No Abstract]   [Full Text] [Related]  

  • 10. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.
    Modena MG; Aveta P; Menozzi A; Rossi R
    Am Heart J; 2001 Jan; 141(1):41-6. PubMed ID: 11136485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary ventricular fibrillation during the acute phase of myocardial infarction (author's transl)].
    Bernard R; Vainsel H; Dereume G; de Hemptinne J; Smets P; Englert M
    Ann Cardiol Angeiol (Paris); 1978 Nov; 27(6):463-5. PubMed ID: 749677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R; Schena FP; Colombo Pirola L
    Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction.
    Di Pasquale P; Cannizzaro S; Scalzo S; Parrinello G; Fasullo S; Giambanco F; Fatta A; Paterna S
    Am Heart J; 2005 Nov; 150(5):919. PubMed ID: 16290961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone blockade in patients with acute myocardial infarction.
    Solomon HA
    Circulation; 2003 Dec; 108(25):E173; author reply E173. PubMed ID: 14691030
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiarrhythmic drugs in prevention of recurrent ventricular fibrillation].
    Szmydt W; Brodzińska K; Luczak J
    Pol Tyg Lek; 1971 Jan; 26(3):99-101. PubMed ID: 5545841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aldosterone antagonists in coronary insufficiency].
    Osswald H
    Med Klin; 1978 Jan; 73(3):84-8. PubMed ID: 622061
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction.
    Lomuscio A; Vergani D; Marano L; Castagnone M; Fiorentini C
    Coron Artery Dis; 1994 Sep; 5(9):767-71. PubMed ID: 7858767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous nicorandil can reduce the occurrence of ventricular fibrillation and QT dispersion in patients with successful coronary angioplasty in acute myocardial infarction.
    Ueda H; Nakayama Y; Tsumura K; Yoshimaru K; Hayashi T; Yoshikawa J
    Can J Cardiol; 2004 May; 20(6):625-9. PubMed ID: 15152293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine.
    Wyman MG; Wyman RM; Cannom DS; Criley JM
    Am J Cardiol; 2004 Sep; 94(5):545-51. PubMed ID: 15342281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
    Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
    Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.